Avery Dennison Medical Virtual Series

Click the links below to view our series of virtual presentations

Avery Dennison Medical’s virtual series brings together leading experts and decision makers to share, discuss and debate our latest adhesive design developments and capabilities. 

You can experience any or all of our webinars and stay connected with professionals from all healthcare specialties, wherever you are. We are thrilled to offer the recordings of our live presentations including the insightful questions from our attendees.

Follow us on Twitter: @admedical

 

Be part of our virtual series where we reveal our innovation plans for the future of adhesives.

Accelerating Growth, Six Innovative Adhesive Technologies

Davy Van Bavel, Research and Development Manager, Europe

An overview of Avery Dennison Medical's approach to innovation, highlighting both market-driven and customer-led developments, focusing on adhesive and design innovations in hydrocolloids, silicones and wound dressings.

PPE Innovations to Protect Frontline Healthcare Workers

Deepak Prakash, Global Marketing Director

The COVID-19 global pandemic has brought about new awareness of Personal Protective Equipment (PPE) on several fronts, especially facepiece respirators.  Our presentation will cover a new innovation in this category which has generally seen little.  New alternatives, like the masks we are offering, could help provide safe and effective options for healthcare workers as they work hard to make a difference in the care they deliver.

The Next Generation of Advanced Wound Care

Dr. Emmett Mcardle, Research and Development Manager
Paul Saunders, Senior Global Marketing Manager

The Next Generation of Advanced Wound Care

Advanced Wound Care continues to bring about growth in innovation.  Avery Dennison Medical will highlight their newest technology in the Silicone Foam market, as well discussing the wide range of capabilities and materials used in our Wound, Ostomy and Skin care products.

Innovations in anti-microbial technology, with BeneHold CHG

Barbara Van Rymenam, Global Director, CHG Program Management

Our unique antimicrobial platform, utilizes Chlorhexidine Gluconate (CHG), a trusted antiseptic in hospital settings. This webinar will showcase this technology and discuss opportunities that exist for collaboration and development.